Roivant Sciences Ltd., Director, 10% Owner at Immunovant, Inc. (IMVT), bought 16,666,666 shares at $21.00 ($350.0M) on 2025-12-12, disclosed to the SEC on 2025-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |
| IMVT | BUY | 2020-04-17 | $30.0M | — | Filing → |